Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier. - Wikidata - awgldk - TriplyDB

Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier.

Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier.

http://www.wikidata.org/entity/Q53330184

about

Update in lung cancer 2007 Lung Cancer Gene Signatures and Clinical Perspectives Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: Immunomodulatory effects of chemotherapy.Prediction of postoperative recurrence-free survival in non-small cell lung cancer by using an internationally validated gene expression model IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions.CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes.Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.Neutrophilic airways inflammation in lung cancer: the role of exhaled LTB-4 and IL-8.MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma.Elevated pretherapy serum IL17 in primary hepatocellular carcinoma patients correlate to increased risk of early recurrence after curative hepatectomy.A combined prognostic serum interleukin-8 and interleukin-6 classifier for stage 1 lung cancer in the prostate, lung, colorectal, and ovarian cancer screening trial Prediagnostic serum levels of inflammatory biomarkers are correlated with future development of lung and esophageal cancer.Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer Control of the MYC-eIF4E axis plus mTOR inhibitor treatment in small cell lung cancer.The role of gene expression profiling in early-stage non-small cell lung cancer.Pathway-based gene signatures predicting clinical outcome of lung adenocarcinoma.An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers.Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer.Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer.Differential Serum Cytokine Levels and Risk of Lung Cancer Between African and European Americans.Radiation and SN38 treatments modulate the expression of microRNAs, cytokines and chemokines in colon cancer cells in a p53-directed manner Inflammation and lung carcinogenesis: applying findings in prevention and treatment.Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancer.Genomics of lung cancer.Discovery of the gene signature for acute lung injury in patients with sepsis The field of tissue injury in the lung and airway.Clinical impact of high-throughput gene expression studies in lung cancer.Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway.Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma.Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians.Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma.Molecular pathways and targets in cancer-related inflammation.Electrochemiluminescence in bioanalysis.Stimulating natural killer cells to protect against cancer: recent developments.Molecular classification of non-small-cell lung cancer: diagnosis, individualized treatment, and prognosis.Scalpel or SABR for Treatment of Early-Stage Lung Cancer: Clinical Considerations for the Multidisciplinary Team.miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells.Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma.

P2860

Q22241904-E800BD82-6851-4D26-A7A5-C8AEAF2E067A Q28387769-6F7FA7CA-F63D-45DF-B11D-E61C54CF4631 Q28743229-1EB81E3D-34C8-45B4-8921-611C990F2E6C Q30376149-9D6CE6BD-A2CB-4014-9259-BC3FDB76D6BB Q30500051-83B4F027-A0F0-49EE-B605-CB0C8BB8BCA0 Q33479161-D08E507D-5163-4374-9112-62E999B56211 Q33562564-819A2DFE-E751-469D-9CE8-D4538F1BEB86 Q33575734-D56FD7EA-8D30-44A5-9FB7-FAF2C3275177 Q33925759-D7ADACFC-49FA-4A30-80FC-2A60AC201BC0 Q34102917-287FC917-FC7F-48C1-81F1-FDA1AD5B24A8 Q34393702-91CDBA42-F701-4A42-9119-A269447ABC53 Q34506935-5C37764F-063D-434F-99CA-714A9A2EA31D Q34747013-917A3CD6-81CD-4FF3-9B10-697204524EE2 Q35007052-6823A4FA-2964-44C8-A0DB-9BED2AFC9C39 Q35115253-755E0EF8-1122-4B60-933F-227BCBF77EDE Q35605425-921A5B48-820E-4B74-889C-AD9CEF5F3301 Q35667675-9114373A-7D6B-456B-99C9-8B42E1AD37D3 Q35682415-BED0B078-5A36-4875-835E-E6E2BF079E4B Q35825840-46C45C56-DDD4-4DA6-BA21-B4AD0F4D905B Q36030366-6DF7D95D-70CD-42FA-BF65-309D4FB99C73 Q36044341-43CAE072-3566-4FE4-AC9D-D6F62776098B Q36655943-329F538A-2E98-4E09-AEFA-84B0769BE46D Q36689088-6A112892-8242-427D-8F9D-43BDADA66E14 Q36974700-68CB9835-0348-458E-9557-FE962790CEEB Q37032881-A8CE8CB9-0C53-4151-84B4-750AD63347ED Q37171910-CE7EB4C0-E550-446D-BF18-F21D2D888C30 Q37175816-3DB152CB-FEDC-4553-B523-BFD07CC43C66 Q37250499-C1D9C001-CEE2-44E4-A4FE-5EF6CAEA0A21 Q37317171-5871001D-B6D6-4CAF-A454-008898C85704 Q37327489-6E5DA25C-4DD7-47E7-948B-09EE118FDA37 Q37350337-B2CC27EA-1217-44FB-80A3-7491FD3E2EB6 Q37464721-BA4011D4-5B74-4278-AEA4-964145B3FBB2 Q37711636-28A19F56-0394-4F80-BE1F-274A77AD1A88 Q37729131-70C89944-48B0-4D0B-80DF-2019342B8131 Q37810142-55875277-7A4C-4BAF-9AAC-5C0C26C8D505 Q37877269-B7F633E7-CBD7-49DD-97EB-C8A1CE9E6077 Q38107464-7B128480-8B2B-4DC6-AEC7-2FF2144DBDDC Q38161371-C74194A0-2A85-4E36-AB23-4724DD7B1416 Q38366840-BCC47627-3B7F-4DFF-8342-6D3166213189 Q38840370-A39F0801-C187-40FD-B6D9-E0709B34983C

P2860

Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier.

http://www.wikidata.org/entity/Q53330184

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Use of a cytokine gene express ...... ue as a prognostic classifier.

@en

Use of a cytokine gene express ...... ue as a prognostic classifier.

@nl

type

label

Use of a cytokine gene express ...... ue as a prognostic classifier.

@en

Use of a cytokine gene express ...... ue as a prognostic classifier.

@nl

prefLabel

Use of a cytokine gene express ...... ue as a prognostic classifier.

@en

Use of a cytokine gene express ...... ue as a prognostic classifier.

@nl

P1433

Q53330184-DB794857-2E80-46A0-9775-310D108B2C52

P1476

Q53330184-9211DACD-9167-4199-934C-39B3025B5E1A

P2093

Q53330184-11310C9E-AB14-4E6E-8CFF-FEEA06510F8B

Q53330184-168AB93D-3FA3-4A1F-BACB-E76A119F49A0

Q53330184-1B3267FD-ED26-4EC7-910F-D32AC80F03EA

Q53330184-20B29226-C7D3-4CD3-B564-08A1282C97FA

Q53330184-3CB5935C-D9CD-458A-A2A7-373DB97369FF

Q53330184-4FA64138-42D3-49D8-BBEF-AA1F2ACCE66D

Q53330184-5A67B807-B65D-47A0-A0C2-A9CA835B7449

Q53330184-82C89585-4F42-4A37-BC41-48BE612CCD09

Q53330184-913436BD-13C3-43E7-97CC-B48955D6FCE0

Q53330184-9829A0EF-3AFC-4653-A77D-6E88B7F6F090

P2860

Q53330184-01E0BF54-556F-4336-A2E6-4CAEAE0D1220

Q53330184-0987B838-9670-41CA-A732-20D0BE6DD813

Q53330184-0C49BDC1-98F2-4B14-8F25-331E7A334AFE

Q53330184-1708ACBD-8510-4F5E-97C4-9EBC5BEE2DD9

Q53330184-2183154A-3529-4A2E-8BA0-391E9C73A994

Q53330184-22C3DDE3-4758-41CF-AD78-EEEE4C3D3C24

Q53330184-2B5B3D46-0E1F-47F6-BA8F-C98C9DCCAC66

Q53330184-3DB75C80-411B-43D1-9B53-F8BC54D67103

Q53330184-40418B01-C169-4CC0-9133-9DAD90C35305

Q53330184-40FA7FB8-511E-43EF-82A5-E05EEA395BE8

P304

Q53330184-263DAA5F-D2E9-4B6D-9282-28982161865C

P31

Q53330184-11CC9D6E-4A64-428D-A4F3-70A0D4423793

P356

Q53330184-24726EB2-769D-41EA-AF77-328ED1530113

P407

Q53330184-A705DED2-CFC6-46C6-BFB2-9B539D1F1C55

P433

Q53330184-DC378434-5981-4301-B778-9A14BE5A266A

P478

Q53330184-93955034-271B-40B0-83AE-C44DBD1EE675

P577

Q53330184-5FFCD111-A1F3-47E5-8ACA-934C5207E060

P5875

Q53330184-57515211-37F0-436C-9D9E-C5D668AF4D86

P698

Q53330184-825104E2-F5B5-48BB-AB2E-221989E9FC7D

P921

Q53330184-F760FADB-428D-45B8-B86A-06C673E9B085

P356

P1433

Journal of the National Cancer Institute

P1476

Use of a cytokine gene express ...... ue as a prognostic classifier.

@en

P2093

Akihiko Gemma

http://www.w3.org/2001/XMLSchema#string

Anuradha Budhu

http://www.w3.org/2001/XMLSchema#string

Curtis C Harris

http://www.w3.org/2001/XMLSchema#string

Elise D Bowman

http://www.w3.org/2001/XMLSchema#string

Haruhiko Sugimura

http://www.w3.org/2001/XMLSchema#string

Jun Yokota

http://www.w3.org/2001/XMLSchema#string

Kensuke Kumamoto

http://www.w3.org/2001/XMLSchema#string

Krista A Zanetti

http://www.w3.org/2001/XMLSchema#string

Leah E Mechanic

http://www.w3.org/2001/XMLSchema#string

Masahiro Seike

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

Gene expression profiling predicts clinical outcome of breast cancer

Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays

Autocrine and paracrine regulation of interleukin-8 expression in lung cancer cells

Revisions in the International System for Staging Lung Cancer

A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung

Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors

Small adenocarcinoma of the lung. Histologic characteristics and prognosis

P304

1257-1269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJM083

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6152405

http://www.w3.org/2001/XMLSchema#string

P698

17686824

http://www.w3.org/2001/XMLSchema#string

P921